Shares of Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the thirteen analysts that are covering the company, Ratings ...
In a report released today, Atidrip Modak from Goldman Sachs maintained a Buy rating on Patterson-UTI (PTEN – Research Report), with a price ...
Patterson-UTI’s earnings were impacted by impairments but still shows strong cash flow. Find out why PTEN stock is a BUY with ...
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response critical for their elimination.
A study published in Science Advances reveals a novel strategy that allows tumors to evade the body's immune response ...
For the quarter ended December 2024, Patterson-UTI (PTEN) reported revenue of $1.16 billion, down 26.7% over the same period last year. EPS came in at -$0.12, compared to $0.19 in the year-ago quarter ...
State of Alaska Department of Revenue reduced its stake in Patterson-UTI Energy, Inc. (NASDAQ:PTEN – Free Report) by 1.2% during the 4th quarter, according to the company in its most recent disclosure ...
VANCOUVER, BC / / February 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H ,WKN:A3EKSZ) ("Onco" or the "Company ...